explore -WSS

explore

author：Wikipedia 2025-09-30 10:56:52 - browse：715

illustration of a colorful DNA strand, partly broken into pieces. -- health coverage from STAT — Adobe

BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators announced Friday morning.

In the study, run by Excision BioTherapeutics, researchers tried to use the gene editing tool to address a chief reason HIV has been so hard to cure. While antiviral drugs can clear patients of replicating virus, HIV is able to worm its way into a patients’ own DNA in certain cells. If the patient ever stops taking medicines, those cells start pumping out HIV particles and the infection roars back.

Researchers hoped they could send CRISPR to those cells and, by cutting the HIV DNA lurking there at two spots, slice out the virus. In the Phase 1 trial, investigators administered the treatment to five patients. They then took three of them off conventional antiviral treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Medicare drug price negotiation legal challenge met with skepticism

hotspot

Wikipedia

WSS

Study: AI not yet building 'n

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Study: People of West African ancestry at greater risk of cardiac amyloidosis

H5N1 bird flu: what we're starting to learn about infection in cows

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Syphilis numbers in the United States reach record heights

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Venture capital firm's plans to take over Akron hospital face hurdles

Trump demands the U.S. pay no more for drugs than other countries … again

Health Care Service Corp to buy Cigna Medicare Advantage plans

Drug repurposing or repositioning? The language matters

Use wet bulb globe temperature, not heat index, to protect workers

At least 13 dead in Texas as scorching temps continue

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

The high cost of giving birth even with insurance

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

explore

Brain worms: The science behind RFK Jr.'s parasitic infection

How generative AI ratchets up security threats for health systems

Use wet bulb globe temperature, not heat index, to protect workers

H5N1 communication has been strictly for the birds

FTC sues over Novant Health acquisition of two N.C. hospitals

New clues to why women have higher risk of autoimmune disorders

hotspot

entertainment

Wikipedia

Wikipedia